Spero Therapeutics, Inc. Business Operations Contracts & Agreements

5 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Revenue Interest Termination Agreement, dated June 7, 2022, by and between Spero Therapeutics, Inc., entities managed by HealthCare Royalty Management, LLC and HCR Collateral...
Termination Agreements
Spero Therapeutics, Inc.
Biotechnology
2022
Revenue Interest Financing Agreement, dated September 29, 2021, by and between Spero Therapeutics, Inc. and entities managed by HealthCare Royalty Management, LLC
Management Agreements
Spero Therapeutics, Inc.
Biotechnology
NY
2021
Controlled Equity Offering Sales Agreement, dated March 11, 2021, by and between the Registrant and Cantor Fitzgerald & Co
Sales Agreements
Spero Therapeutics, Inc.
Biotechnology
NY
2021
Termination and Release, dated April 14, 2017, by and between the Registrant and John Tomayko, M.D
Termination Agreements
Spero Therapeutics, Inc.
Biotechnology
2017
Form of Director and Officer Indemnification Agreement
Indemnification Agreements
Spero Therapeutics, Inc.
Biotechnology
DE
2017